Britta Besemer
- Hematology top 5%
- Multiple Myeloma Research and Treatments 27
-
- CAR-T cell therapy research 9
- Peptidase Inhibition and Analysis 3
-
- Monoclonal and Polyclonal Antibodies Research 6
-
- Chronic Lymphocytic Leukemia Research 3
-
- Protein Degradation and Inhibitors 13
-
- Cancer Mechanisms and Therapy 6
-
- Neuroblastoma Research and Treatments 3
- Co-authors
- Karsten MüssigKatja WeiselPhilippe MoreauAmrita KrishnanNizar J. BahlisCarsten BokemeyerAlfred L. GarfallAjay K. Nooka
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Britta Besemer
32 papers receiving 281 citations
Peers
Comparison fields: 5 of 39
- Hematology 197
- Oncology 160
- Radiology, Nuclear Medicine and Imaging 66
- Genetics 23
- Molecular Biology 147
Countries citing papers authored by Britta Besemer
This map shows the geographic impact of Britta Besemer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britta Besemer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britta Besemer more than expected).
Fields of papers citing papers by Britta Besemer
This network shows the impact of papers produced by Britta Besemer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britta Besemer. The network helps show where Britta Besemer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Britta Besemer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 8 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 26 | |
| 6 | 2024 | 3 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 6 | |
| 10 | 2022 | 26 | |
| 11 | 2022 | 14 | |
| 12 | 2020 | 8 | |
| 13 | 2020 | 12 | |
| 14 | 2020 | 27 | |
| 15 | 2019 | 10 | |
| 16 | 2016 | 2 | |
| 17 | 2010 | 16 | |
| 18 | 2009 | 13 | |
| 19 | 2009 | 1 | |
| 20 | 2009 | 8 |
About Britta Besemer
Britta Besemer is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine, having authored 37 papers that have together received 286 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (27 papers), Protein Degradation and Inhibitors (13 papers), CAR-T cell therapy research (9 papers), Cancer Mechanisms and Therapy (6 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), Chronic Lymphocytic Leukemia Research (3 papers), Neuroblastoma Research and Treatments (3 papers) and Peptidase Inhibition and Analysis (3 papers). The work is most often cited by research in Hematology (197 citations), Oncology (160 citations) and Radiology, Nuclear Medicine and Imaging (66 citations). Britta Besemer has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Karsten Müssig, Katja Weisel, Philippe Moreau, Amrita Krishnan, Nizar J. Bahlis, Carsten Bokemeyer, Alfred L. Garfall, Ajay K. Nooka, Aneta Schieferdecker and Surbhi Sidana. Their work appears in journals such as Journal of Clinical Oncology, Blood and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.